Bradley Saenger
2017
In 2017, Bradley Saenger earned a total compensation of $365.7K as Chief Financial Officer at Tonix Pharmaceuticals Holding, a 2% decrease compared to previous year.
Compensation breakdown
| Option Awards | $30,680 |
|---|---|
| Salary | $335,000 |
| Total | $365,680 |
Saenger received $335K in salary, accounting for 92% of the total pay in 2017.
Saenger also received $30.7K in option awards.
Rankings
In 2017, Bradley Saenger's compensation ranked 12,831st out of 14,666 executives tracked by ExecPay. In other words, Saenger earned more than 12.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,831 out of 14,666 | 13th |
Division Manufacturing | 5,041 out of 5,772 | 13th |
Major group Chemicals And Allied Products | 1,848 out of 2,075 | 11th |
Industry group Drugs | 1,539 out of 1,731 | 11th |
Industry Pharmaceutical Preparations | 1,192 out of 1,333 | 11th |
Source: SEC filing on April 19, 2018.
Saenger's colleagues
We found three more compensation records of executives who worked with Bradley Saenger at Tonix Pharmaceuticals Holding in 2017.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019